CLARISCAN
gadoterate meglumine
- Strength
- 376.9 mg/mL
- Form
- Injection, Solution
- Class
- Gadolinium-based Contrast Agent
GE Healthcare
Not stocked by us — reference only
gadoterate meglumine
Listed by Guerbet LLC
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Gadolinium-based Contrast Agent |
| Approval route | NDA — original brand approval |
| NDC code | 67684-2000 |
| FDA application | NDA204781 |
| Package sizes listed | 1 |
| Marketed since | April 2013 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
gadoterate meglumine
GE Healthcare
Not stocked by us — reference only
gadoterate meglumine
Guerbet LLC
Not stocked by us — reference only
gadoterate meglumine
Guerbet LLC
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Slate Run Pharmaceuticals, LLC
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.